Tiagabine
- Generic Name
- Tiagabine
- Brand Names
- Gabitril
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25NO2S2
- CAS Number
- 115103-54-3
- Unique Ingredient Identifier
- Z80I64HMNP
- Background
Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a selective GABA reuptake inhibitor.
- Indication
For the treatment of partial seizures
- Associated Conditions
- Partial-Onset Seizures
- Associated Therapies
- -
Tiagabine for the Treatment of Cocaine Dependence - 1
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-06-30
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 140
- Registration Number
- NCT00086255
- Locations
- 🇺🇸
Cincinnati VA Medical Center, Cincinnati, Ohio, United States
🇺🇸Boston University Medical Center, Boston, Massachusetts, United States
🇺🇸University of Texas Hlth Sci Ctr Houston, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath